hyperglycemia in critical care unit patients MedDRA version: 9.1 Level: HLGT Classification code 10018424 Term: Glucose metabolism disorders (incl diabetes mellitus)
Conditions
Interventions
Trade Name: Insuline aspartate
Product Name: NOVORAPID
Pharmaceutical Form: Solution for injection
INN or Proposed INN: insuline aspartate
Concentration unit: U/ml unit(s)/millilitre
Concentration typ
Sponsors
Poissy Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Adults patients admitted in intensive car unit and requiring a mechanical ventilation with a duration estimated above 48 hours. Consent obtained from the patient or the next of kin Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: Transfer from an another Intensive Care Unit, Admission for cardiac arrest or drug overdose or acido-cetosis Pregnancy Consent non obtained Inclusion in an another clinical study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: reduction of hospital mortality;Secondary Objective: reduction of intensive care mortality, incidence of severe hypoglycemia (defined by a glycemia below 2.2 mmol/l, incidence of critical illness neuromuscular syndromes;Primary end point(s): Reduction of Hospital Mortality | — |
Countries
France
Outcome results
None listed